Cardiovascular Events

Heart-Specific Mortality Not Higher Among Breast Cancer Survivors

Heart-Specific Mortality Not Higher Among Breast Cancer Survivors

By

A retrospective cohort study of data from the SEER database assessed the potential risk of cardiac-related mortality in patients with breast cancer, treated with chemotherapy or radiotherapy, vs the general population.

1-year Imatinib or Nilotinib Therapy Not Associated with Cardiotoxity in CML

1-year Imatinib or Nilotinib Therapy Not Associated with Cardiotoxity in CML

By

Although many TKIs have well-documented cardiotoxic effects, results of a single-center prospective study that assessed effects of 1 year of therapy with imatinib or nilotinib in patients with CML demonstrated safety and efficacy of the 2 agents in this population.

Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer

Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer

By

Results from the ongoing Platinum Study revealed the prevalence of risk factors for CVD among survivors of testicular cancer who received chemotherapy for their cancer.

Cancer History Impacts Mortality, Independent of CVRFs

Cancer History Impacts Mortality, Independent of CVRFs

Independent of cardiovascular risk factors, a history of cancer is a significant factor in future longevity.

Cardiovascular Disease Risks Greater With ITP, Especially After Splenectomy

Cardiovascular Disease Risks Greater With ITP, Especially After Splenectomy

By

Idiopathic thrombocytopenic purpura (ITP) may be linked to an increased risk of cardiovascular disease, but studies have not been conclusive.

New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment

New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment

By

Publication of the JNC 8 introduces a lower threshold for initiating hypertension treatment during cancer therapy.

Breast Cancer Therapies Associated With Increased Risk for Cardiovascular Disease

Breast Cancer Therapies Associated With Increased Risk for Cardiovascular Disease

By

Advances in breast cancer treatment are improving outcomes for patients with the disease; however, treatments are increasing these patients' risk for cardiovascular diseases.

Breast Cancer Recurrence and CV Risks Down With Exercise in Survivors

Breast Cancer Recurrence and CV Risks Down With Exercise in Survivors

Exercise intervention was associated with improved z-score and serum biomarkers in obese survivors of breast cancer.

Carfilzomib Associated With Cardiovascular Adverse Events in Multiple Myeloma

Carfilzomib Associated With Cardiovascular Adverse Events in Multiple Myeloma

By

For this meta-analysis and systematic review, investigators compiled phase 1 to 3 prospective clinical trials of carfilzomib therapy for patients with MM that had evaluable toxic effects data.

Incorporating Cardiac Care in the Oncology Setting

Incorporating Cardiac Care in the Oncology Setting

By

Cardio-oncology is an emerging interdisciplinary practice poised to address care patients who need concurrent cancer and cardiovascular disease therapies as well as the late effects of cancer and cancer treatments.

Arterial Thrombotic Events Associated With First-line Nilotinib for CML in Older Adults

Arterial Thrombotic Events Associated With First-line Nilotinib for CML in Older Adults

A retrospective analysis of patients with CML determined prevalence of arterial thrombotic events in those receiving nilotinib as first-line treatment and prevalence by patient age. Data were presented at ASH 2017.

Markers Identified for Cardiotoxicity Due to Chemotherapy for Breast Cancer

Markers Identified for Cardiotoxicity Due to Chemotherapy for Breast Cancer

By

Biomarker analysis revealed markers for cardiotoxicity enabling early initiation of heart failure therapy in patients with breast cancer who were treated with chemotherapy.

Androgen Deprivation Therapy for Prostate Cancer Increases Risk of CVD

Androgen Deprivation Therapy for Prostate Cancer Increases Risk of CVD

By

The risk of cardiovascular disease such as heart failure, arrhythmias, and conduction disorders are greater in men with localized prostate cancer who were treated with androgen deprivation therapy.

Cause of Superior Vena Cava Syndrome in Cancer Determines Prognosis

Cause of Superior Vena Cava Syndrome in Cancer Determines Prognosis

By

Prognosis for cancer patients with superior vena cava syndrome is highly associated with the underlying cause of the syndrome.

Risk of Arterial Thromboembolism Greater With First-Time Cancer

Risk of Arterial Thromboembolism Greater With First-Time Cancer

By

An increase in risk for arterial thromboembolism was correlated with cancer stage and varied by cancer type.

CVD Risk Factors Identified in Long-Term Survivors of Pediatric Cancer

CVD Risk Factors Identified in Long-Term Survivors of Pediatric Cancer

By

Study implicates higher doses of cardiac radiotherapy and exposure to high-dose anthracyclines.

High CVD Risk in Patients With Head, Neck Squamous Cell Cancer

High CVD Risk in Patients With Head, Neck Squamous Cell Cancer

Twenty-three percent of patients with HNSCC had CVD at the time of their diagnosis.

Two Exercise Sessions Per Week Linked To Lower Mortality From Cancer and Cardiovascular Disease

Two Exercise Sessions Per Week Linked To Lower Mortality From Cancer and Cardiovascular Disease

By

Both men and women who exercised 1 to 2 days each week conferred significant health benefits.

Age of Cancer Diagnosis Key in Determining Future Cardiac Risk

Age of Cancer Diagnosis Key in Determining Future Cardiac Risk

The younger the age at diagnosis, the greater the cardiac event risk, study suggests.

Drug Prevents Heart Damage in Pediatric Patients Receiving Chemotherapy

Drug Prevents Heart Damage in Pediatric Patients Receiving Chemotherapy

By

Dexrazoxane has cardioprotective properties that can prevent long-term cardiotoxicity in pediatric patients receiving chemotherapy, according to a review of the medical literature on cardiotoxic effects of anthracycline treatment.

Cancer Risk Higher in Patients With Heart Failure After a First Heart Attack

Cancer Risk Higher in Patients With Heart Failure After a First Heart Attack

By

The risk of developing cancer increases in people who experience heart failure after their first heart attack compared with people who experience no heart failure after their first heart attack.

Long-Acting Opioids May Increase All-Cause Mortality Risk

Long-Acting Opioids May Increase All-Cause Mortality Risk

Much of the risk related to long-acting opioids is tied to cardiovascular complications, not overdoses.

Exercise Cuts Cardiac Events in Non-Metastatic Breast Cancer

Exercise Cuts Cardiac Events in Non-Metastatic Breast Cancer

The incidence of cardiovascular events was down for patients with non-metastatic breast cancer that exercise.

Risk for Fatal Cardiovascular Events Not Increased in Patients With Breast Cancer Taking Aromatase Inhibitors

Risk for Fatal Cardiovascular Events Not Increased in Patients With Breast Cancer Taking Aromatase Inhibitors

By

Risk of the most serious cardiovascular events, cardiac ischemia and stroke, were not increased in breast cancer patients taking aromatase inhibitors compared with tamoxifen users.

AI-only Users vs Tamoxifen Users Have Similar CVD Risk

By

The risk of the most serious cardiovascular events, including cardiac ischemia and stroke, was not higher for breast cancer survivors who received an aromatase inhibitor (AI) compared with tamoxifen users.

It Is Never Too Late for Breast Cancer Survivors to Stop Smoking

It Is Never Too Late for Breast Cancer Survivors to Stop Smoking

By

Smokers have good reason to quit the habit both before and after a breast cancer diagnosis.

Risk of Metabolic Syndrome Increased in Survivors of Childhood Cancer

By

Early cardiovascular events are a risk for survivors of childhood cancer, according to researchers who also advocate for a unified definition of pediatric metabolic syndrome.

Cardiovascular Disease Risk Higher Among Adult-onset Cancer Survivors

Cardiovascular Disease Risk Higher Among Adult-onset Cancer Survivors

By

Risk for cardiovascular disease (CVD) in survivors of adult-onset cancer varies according to cancer type.

Expert Consensus Statement Guides Management of Cardiovascular Treatments for Patients With Cancer

By

The Society for Cardiovascular Angiography and Interventions released an expert consensus statement providing guidance for managing the treatment of patients facing concomitant cardiovascular disease and cancer.

Vasculature-related Effects After Anthrocycline-containing Chemotherapy Not Long-term

Vasculature-related Effects After Anthrocycline-containing Chemotherapy Not Long-term

By

Cardiovascular effects after treatment with anthracycline-containing chemotherapy (Anth-C) appear to be isolated to the heart.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs